Seung KJ, Khan UT, Varaine FFV, Ahmed SM, Bastard M, et al.
2020-10-01 • International Journal of Tuberculosis and Lung Disease
2020-10-01 • International Journal of Tuberculosis and Lung Disease
In 2015, the initiative Expand New Drug Markets for TB (endTB) began, with the objective of reducing barriers to access to the new and repurposed TB drugs. Here we describe the major imp...
Polonsky JA, Ivey M, Mazhar KA, Rahman Z, le Polain de Waroux O, et al.
2021-04-01 • PLOS Medicine
2021-04-01 • PLOS Medicine
BACKGROUND Unrest in Myanmar in August 2017 resulted in the movement of over 700,000 Rohingya refugees to overcrowded camps in Cox's Bazar, Bangladesh. A large outbreak of diphtheria...
Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, et al.
2021-09-25 • Trials
2021-09-25 • Trials
BACKGROUND Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial adverse events and poor outcomes. W...
BACKGROUND At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaqui...
